Today's Low | Today's High | |
---|---|---|
256.85 257.00 |
| 275.25 273.50 |
52 Week Low | 52 Week High | |
---|---|---|
142.00 (06-Nov-2023) 142.60 (06-Nov-2023) |
| 287.50 (16-Sep-2024) 288.00 (16-Sep-2024) |
Buy Order Quantity | Sell Order Quantity | |
---|---|---|
182 | 0 |
Bid Price | Quantity |
---|---|
258.95 | 182.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | 182 |
Ask Price | Quantity |
---|---|
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | -- |
Market Cap: | ₹23.90 Cr |
PE Ratio (TTM): | 82.04 |
PB Ratio: | 8.42 |
Industry P/E: | 82.06 |
Debt to Equity: | 0.00 |
ROE: | 10.26 |
EPS (TTM): | 3.36 |
Book Value: | 321.64 |
Face Value: | 1.00 |
Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
---|---|---|---|---|---|
Revenue | 104.78 Cr | 96.65 Cr | 80.10 Cr | 88.78 Cr | 91.00 Cr |
Profit | 7.10 Cr | 12.56 Cr | 6.04 Cr | 12.09 Cr | 13.53 Cr |
Expense | 97.48 Cr | 80.42 Cr | 75.12 Cr | 78.41 Cr | 74.60 Cr |
Comprehensive income | 6.99 Cr | 12.45 Cr | 5.85 Cr | 12.01 Cr | 13.45 Cr |
EPS | 7.70 | 13.62 | 6.55 | 13.11 | 14.68 |
Company name | Listing date | Industry | NSE symbol BSE symbol |
---|---|---|---|
Themis Medicare Limited | Apr, 2007 May, 1995 | Pharmaceuticals Pharmaceuticals | THEMISMED THEMISMED |
Promoters | |
---|---|
67.16% |
Public | |
---|---|
32.84% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
67.16% |
Public | |
---|---|
32.84% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
67.16% |
Public | |
---|---|
32.84% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
67.18% |
Public | |
---|---|
32.82% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
67.18% |
Public | |
---|---|
32.82% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Today's stock performance witnessed a fluctuation from a minimum of 256.85 on the NSE (National Stock Exchange) to a maximum of 275.25. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 257.00 to a high of 273.50.
The stock's performance over the past 52 weeks reveals a low of 142.00 (occurred on 06-Nov-2023) and a high of 287.50 (achieved on 16-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 142.60 (on 06-Nov-2023), and the 52-week high is 288.00 (on 16-Sep-2024).
The stock's performance over the past 52 weeks reveals a low of 142.00 (occurred on 06-Nov-2023) and a high of 287.50 (achieved on 16-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 142.60 (on 06-Nov-2023), and the 52-week high is 288.00 (on 16-Sep-2024).
The total volume is 2, and the total traded value is 5.14 (₹ Lakhs).
The upper circuit limit is 330.30, and the lower circuit limit is 220.20.
The market cap is ₹23.90 Cr, and the PE ratio (TTM) is 82.06.
The PB ratio is 0.81, industry P/E is 82.06 , and the debt to equity ratio is 0.00.
ROE is 10.26, EPS is 3.36, book value is 321.64
In Sep 2023, Revenue is ₹1047824000.00, and Profit is ₹70988000.00. In Jun 2023, Revenue is ₹966482000.00, and Profit is ₹125552000.00.
The company, Themis Medicare Limited, was listed in Apr 2007 and belongs to the Pharmaceuticals industry. Its NSE symbol is THEMISMED.
As of latest available update, promoters hold 67.16%, the public holds 32.84%, and Employee Trusts holds 0.00.
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.